Skip to page content

Site-wide navigation

Topics
Trending
Topics
All Topics
Research & Commentary
Experts
About

Research Divisions
RAND's divisions conduct research on a uniquely broad front for clients around the globe.
- Federally Funded Research Divisions
- Social and Economic Policy Divisions
- RAND Global and Emerging Risks
- International
  - RAND Europe
  - RAND Australia
Services & Impact
Careers
Graduate School
Give
Cart

Toggle Search

Site-wide Search

RAND
Topics
>Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial Resistance

Related Topics

Antibiotics
Global Health
Public Health

Research

The Economic Costs of Antimicrobial Resistance

Dec 11, 2014
Commentary

Europe's Fight Against Antimicrobial Resistance

Nov 3, 2016

Explore RAND’s Work on this Topic

Skip to results

Search by keyword

Content Type
- Research (18)
- Commentary (11)
- Project (11)
- Press (1)
- Research Summary (1)
Region
Most relevant regions
- Europe (10)
- United Kingdom (4)
- Americas (2)
- North America (2)
- Canada (1)
- Norway (1)
- United States (1)
Date

to

49 Results

number of items to display at a time

Error

Jan 26, 2016

Spotlight on 2015

RAND Europe's annual review, Spotlight on 2015, illustrates how our work helps to improve people's lives through policymaking based on objective research and rigorous analysis.
Project

Oct 1, 2015

Advising the Development of Public Health Guidelines to Delay Antimicrobial Resistance

RAND Europe is reviewing the evidence of effectiveness, cost effectiveness, and related qualitative evidence relating to changing risk-related behaviours pertaining to antimicrobial use to inform the development of Department of Health/NICE guidelines aimed at delaying antimicrobial resistance.
Research

Sep 30, 2015

Antimicrobial stewardship: The effectiveness of educational interventions to change risk-related behaviours in the general population: A systematic review

A systematic review of the evidence of effectiveness and cost-effectiveness on changing the public's risk related behaviour pertaining to antimicrobial use to inform a NICE public health guideline aimed at delaying antimicrobial resistance.
Commentary

Aug 7, 2015

The Cost of Resistance and the Attack of the Microbes

If left unaddressed, the threat posed by antimicrobial resistance and the rise of 'superbugs' could devastate the world economy and pose a deadly threat to humanity.
Commentary

Jun 8, 2015

G7 Leaders to Discuss Threat of Antimicrobial Resistance

The threat of drug resistance can be tackled with the right set of actions, including the development of new antimicrobial drugs and alternative therapies to disrupt the rise in resistance. German Chancellor Merkel has emphasized the importance of a joint global action plan for addressing this growing problem.
Mar 4, 2015

RAND Review: March-April 2015

This issue of RAND Review reports on American jihadists and the threat of homegrown terrorism in Europe, drug-resistant superbugs and the economic costs of antimicrobial resistance, profiling, resilient cities, and recent philanthropic gifts to RAND.
Commentary

Feb 20, 2015

Ringing the Alarm Bell for Antimicrobial Resistance

The increase in the number of bacterial and viral infections that are resistant to antimicrobial drugs poses a growing global health threat.
Project

Dec 11, 2014

Estimating the Economic Costs of Antimicrobial Resistance

The costs of failing to tackle antimicrobial resistance (AMR) include a world population by 2050 that will be between 11 million and 444 million lower than it would otherwise be in the absence of AMR, and world GDP losses between $2.1 and $124.5 trillion.
Research

Dec 10, 2014

Estimating the economic costs of antimicrobial resistance: Model and Results

The independent Review on AMR led by the economist Jim O'Neill commissioned RAND Europe to conduct a study estimating the global costs of antimicrobial resistance until 2050 in the absence of any progress in tackling the challenge.
Commentary

Oct 28, 2013

The Most Dangerous Mistake You Can Make During Flu Season

Despite public awareness campaigns in the United States and Europe, many people persist in the mistaken belief that antibacterial drugs — like amoxicillin and azithromycin — are the best treatment for flu. And many doctors simply surrender when patients demand them, ignoring the scientific and medical truth: when treating the flu, antibacterial drugs just don't work.
Sep 18, 2013

The Drugs Don't Work: A Global Threat

The Drugs Don't Work brings together in one easy read the startling facts of the here-and-now problem we face about resistance to our current range of antimicrobial drugs.
Commentary

Sep 18, 2013

Who Killed Mrs X? The Global Threat of Antimicrobial Resistance

Antimicrobial drugs are no longer working as they once did. The bugs that they are supposed to attack are becoming increasingly resistant. Microbes follow the same rules of evolution as we do. Through reproduction and natural selection the fittest survive.

Previous
1
2
3
4
5
Next

Oops! An unexpected error has occurred.

Please try again. If you see this message repeatedly, there may be a problem with site functionality at this time. Thanks for your patience while we work to resolve the problem.

Subscribe to the Policy Currents newsletter

Email

View all newsletters

Objective Analysis. Effective Solutions.

RAND is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest.

RAND Headquarters

P.O. Box 2138 
1776 Main Street
Santa Monica, CA 90401-2138

RAND has offices across the U.S., in Europe, and in Australia

See all RAND locations

About
Leadership
Research Integrity
Graduate School
Support RAND
Careers
Contact
Work with Us
For Media
For Congress

Subscribe to the Policy Currents Newsletter

And stay on top of the issues that matter most.

Email

View all newsletters

RAND on LinkedIn
RAND on Twitter
RAND on Facebook
RAND on YouTube
RAND on Instagram
Policy Currents Podcast

RAND® is a registered trademark. © 2025 RAND Corporation.

Privacy Policy Terms and Conditions

International Websites:: 中文; العربية

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.